Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank21
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-288.28M
↓ 41% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-204.15M
Historical baseline
PeriodValueYoY Change
TTM$-288.28M+38.1%
2024$-465.89M-24.7%
2023$-373.63M-26.5%
2022$-295.35M-22.1%
2021$-241.85M-19.6%
2020$-202.24M-140.9%
2019$-83.95M-155.9%
2018$-32.81M-5.3%
2017$-31.15M-18.1%
2016$-26.39M-